approval · primary record
RANIBIZUMAB-LEYK
FDA · BLA · 2025-12-18
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-12-18 |
| Brand | NUFYMCO |
| Sponsor | FORMYCON AG |
| Route | Not stated |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:42.164Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:RANIBIZUMAB-LEYK:2025-12-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ranibizumab-Leyk · compound